Intevac Announces First Quarter 2019 Financial Results
Mon, April 29 2019
“We were pleased to deliver first-quarter results that were stronger
than forecast, due to upside in our hard drive system upgrades business
and continued close control of expenses,” commented
($ Millions, except per share amounts) | Q1 2019 | Q1 2018 | |||||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | ||||||||||||||
Net Revenues | $ | 24.8 | $ | 24.8 | $ | 18.0 | $ | 18.0 | |||||||||
Operating Loss | $ | (2.0 | ) | $ | (2.0 | ) | $ | (5.1 | ) | $ | (5.0 | ) | |||||
Net Loss | $ | (2.4 | ) | $ | (2.4 | ) | $ | (5.1 | ) | $ | (5.0 | ) | |||||
Net Loss per Diluted Share | $ | (0.10 | ) | $ | (0.10 | ) | $ | (0.23 | ) | $ | (0.23 | ) | |||||
Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) changes in fair value of contingent consideration liabilities associated with business combinations; and (2) restructuring charges. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section.
First Quarter 2019 Summary
The net loss was
Revenues were
TFE gross margin was 31.5%, compared to 35.6% in the first quarter of 2018, and compared to 30.6% in the fourth quarter of 2018. The decline from the first quarter of 2018 was primarily due to lower margin contribution from four ENERGi solar ion implant systems. Photonics gross margin was 21.5%, compared to 6.2% in the first quarter of 2018 and 42.1% in the fourth quarter of 2018. The improvement from the first quarter of 2018 was due to higher revenue levels and higher margins on technology development contracts. The decline from the fourth quarter of 2018 was due to lower sales of higher-margin products. Consolidated gross margin was 29.2%, compared to 27.1% in the first quarter of 2018 and 33.5% in the fourth quarter of 2018.
R&D and SG&A expenses were
Order backlog totaled
The Company ended the quarter with
Use of Non-GAAP Financial Measures
Management uses non-GAAP results to evaluate the Company’s operating and
financial performance in light of business objectives and for planning
purposes. These measures are not in accordance with GAAP and may differ
from non-GAAP methods of accounting and reporting used by other
companies.
Conference Call Information
The Company will discuss its financial results and outlook in a
conference call today at
About
In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.
In our Photonics business, we are a recognized leading developer of
advanced high-sensitivity digital sensors, cameras and systems that
primarily serve the defense industry. We are the provider of integrated
digital imaging systems for most
For more information call 408-986-9888, or visit the Company's website at www.intevac.com.
200 Lean®, INTEVAC MATRIX®,
INTEVAC VERTEX®, oDLC® and ENERGi® are
registered trademarks of
Safe Harbor Statement
This press release includes statements that constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995 (the “Reform Act”).
|
|||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||
(Unaudited, in thousands, except per share amounts) |
|||||||||
Three months ended | |||||||||
|
|
||||||||
Net revenues | |||||||||
TFE | $ | 18,945 | $ | 12,789 | |||||
Photonics | 5,882 | 5,185 | |||||||
Total net revenues | 24,827 | 17,974 | |||||||
Gross profit | 7,239 | 4,875 | |||||||
Gross margin |
|||||||||
TFE | 31.5 | % | 35.6 | % | |||||
Photonics | 21.5 | % | 6.2 | % | |||||
Consolidated | 29.2 | % | 27.1 | % | |||||
Operating expenses | |||||||||
Research and development | 3,986 | 4,167 | |||||||
Selling, general and administrative | 5,245 | 5,830 | |||||||
Acquisition-related1 | 7 | (1 | ) | ||||||
Total operating expenses | 9,238 | 9,996 | |||||||
Total operating loss | (1,999 | ) | (5,121 | ) | |||||
Operating loss | |||||||||
TFE | (603 | ) | (2,509 | ) | |||||
Photonics | (640 | ) | (1,210 | ) | |||||
Corporate | (756 | ) | (1,402 | ) | |||||
Total operating loss | (1,999 | ) | (5,121 | ) | |||||
Interest and other income | 160 | 145 | |||||||
Loss before income taxes | (1,839 | ) | (4,976 | ) | |||||
Provision for income taxes | 553 | 160 | |||||||
Net loss | $ | (2,392 | ) | $ | (5,136 | ) | |||
Net loss per share | |||||||||
Basic and Diluted | $ | (0.10 | ) | $ | (0.23 | ) | |||
Weighted average common shares outstanding | |||||||||
Basic and Diluted | 22,855 | 22,107 | |||||||
1 Amounts for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.
|
|||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||
(In thousands, except par value) |
|||||||||
|
|
||||||||
(Unaudited) | (see Note) | ||||||||
ASSETS | |||||||||
Current assets | |||||||||
Cash, cash equivalents and short-term investments | $ | 35,301 | $ | 34,791 | |||||
Accounts receivable, net | 19,996 | 27,717 | |||||||
Inventories | 30,329 | 30,597 | |||||||
Prepaid expenses and other current assets | 2,173 | 2,528 | |||||||
Total current assets | 87,799 | 95,633 | |||||||
Long-term investments | 5,394 | 4,372 | |||||||
Restricted cash | 1,254 | 1,169 | |||||||
Property, plant and equipment, net | 10,550 | 11,198 | |||||||
Operating lease right-of-use-assets | 11,076 | — | |||||||
Intangible assets, net | 735 | 889 | |||||||
Deferred income tax and other long-term assets | 8,485 | 8,809 | |||||||
Total assets | $ | 125,293 | $ | 122,070 | |||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||
Current liabilities | |||||||||
Current operating lease liabilities | $ | 2,569 | $ | — | |||||
Accounts payable | 4,867 | 6,053 | |||||||
Accrued payroll and related liabilities | 3,457 | 4,689 | |||||||
Other accrued liabilities | 4,327 | 4,952 | |||||||
Customer advances | 10,335 | 14,314 | |||||||
Total current liabilities | 25,555 | 30,008 | |||||||
Non-current liabilities | |||||||||
Non-current operating lease liabilities | 10,491 | — | |||||||
Other long-term liabilities | 160 | 2,438 | |||||||
Total non-current liabilities | 10,651 | 2,438 | |||||||
Stockholders’ equity | |||||||||
Common stock ( |
23 | 23 | |||||||
Additional paid in capital | 184,953 | 183,204 | |||||||
|
(29,047 | ) | (29,047 | ) | |||||
Accumulated other comprehensive income | 484 | 378 | |||||||
Accumulated deficit | (67,326 | ) | (64,934 | ) | |||||
Total stockholders’ equity | 89,087 | 89,624 | |||||||
Total liabilities and stockholders’ equity | $ | 125,293 | $ | 122,070 | |||||
Note: Amounts as of
|
|||||||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS | |||||||||
(Unaudited, in thousands, except per share amounts) |
|||||||||
Three months ended | |||||||||
|
|
||||||||
Non-GAAP Loss from Operations | |||||||||
Reported operating loss (GAAP basis) | $ | (1,999 | ) | $ | (5,121 | ) | |||
Change in fair value of contingent consideration obligations1 | 7 | (1 | ) | ||||||
Restructuring charges2 | — | 95 | |||||||
Non-GAAP Operating Loss | $ | (1,992 | ) | $ | (5,027 | ) | |||
Non-GAAP Net Loss | |||||||||
Reported net loss (GAAP basis) | $ | (2,392 | ) | $ | (5,136 | ) | |||
Change in fair value of contingent consideration obligations1 | 7 | (1 | ) | ||||||
Restructuring charges2 | — | 95 | |||||||
Income tax effect of non-GAAP adjustments3 | — | — | |||||||
Non-GAAP Net Loss | $ | (2,385 | ) | $ | (5,042 | ) | |||
Non-GAAP Net Loss Per Share | |||||||||
Reported net loss per share (GAAP basis) | $ | (0.10 | ) | $ | (0.23 | ) | |||
Change in fair value of contingent consideration obligations1 | — | — | |||||||
Restructuring charges2 | — | — | |||||||
Non-GAAP Net Loss Per Share | $ | (0.10 | ) | $ | (0.23 | ) | |||
Weighted average number of diluted shares outstanding | 22,855 | 22,107 | |||||||
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.
2Results for the quarter ended
3The amount represents the estimated income tax effect of the non-GAAP adjustments. The Company calculated the tax effect of non-GAAP adjustments by applying an applicable estimated jurisdictional tax rate to each specific non-GAAP item.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190429005155/en/
Chief Financial Officer
(408) 986-9888
Investor Relations
(530) 265-9899
Source: